Evidence map›Paper›PMID 33637674›Full record

ArticleSignal transduction and targeted therapy2021

Correction: Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy.

Ajaz A Bhat, Parvaiz Yousuf, Nissar A Wani, Arshi Rizwan, Shyam S Chauhan, Mushtaq A Siddiqi, Davide Bedognetti, Wael El-Rifai, Michael P Frenneaux, Surinder K Batra and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Signal transduction and targeted therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Ajaz A Bhat *Functional and Molecular Imaging Laboratory, Cancer Research Department, Sidra Medicine, Doha, Qatar.
Parvaiz Yousuf *Department of Zoology, School of Life Sciences, Central University of Kashmir, Ganderbal, Jammu & Kashmir, India.ORCID http://orcid.org/0000-0002-6465-9096
Nissar A WaniDepartment of Biotechnology, School of Life Sciences, Central University of Kashmir, Ganderbal, Jammu & Kashmir, India.
Arshi RizwanDepartment of Nephrology, All India Institute of Medical Sciences, New Delhi, India.
Shyam S ChauhanDepartment of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
Mushtaq A SiddiqiWatson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology, Awantipora, Jammu & Kashmir, India.
Davide BedognettiLaboratory of Cancer Immunogenomics, Cancer Research Department, Sidra Medicine, Doha, Qatar.
Wael El-RifaiDepartment of Surgery, University of Miami, Miami, FL, USA.
Michael P FrenneauxAcademic Health System, Hamad Medical Corporation, Doha, Qatar.
Surinder K BatraDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.ORCID http://orcid.org/0000-0001-9470-9317
Mohammad HarisFunctional and Molecular Imaging Laboratory, Cancer Research Department, Sidra Medicine, Doha, Qatar. mharis@sidra.org.
Muzafar A MachaWatson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology, Awantipora, Jammu & Kashmir, India. muzafar.aiiims@gmail.com.ORCID http://orcid.org/0000-0003-4468-4435

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33637674
PMCPMC7910536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.